GFAP/C3-positive astrocytes subpopulations have been reported in numerous brain samples from neurodegenerative disease patients such as Alzheimer's disease, multiple sclerosis, Huntington's disease, Parkinson's disease, and ALS [67, 95, 96]. Here, GFAP is linked to early-onset autosomal dominant Alzheimer disease.